Top 6 EDC Platforms for Lean Medical Device Teams (2026)

Your clinical team might be three people, not thirty, and every week spent configuring a database is a week not spent moving your device toward its next regulatory milestone. Viedoc's electronic data capture (EDC) software is built for that reality: a low-code Designer your own team can run, device-specific study fields instead of pharma terminology retrofitted for your protocol, and a database that can go live in as little as one day for simpler studies. This comparison evaluates six EDC platforms against what matters most to a lean device team: device-specific design, self-service builds, regulatory reach, and support that doesn't assume a full-time EDC administrator.

You're not running one trial. You're running a CE-marking study this year, a 510(k) submission next year, and probably a post-market surveillance obligation on the horizon, all with the same two or three people configuring and troubleshooting the database. Every hour your data manager spends waiting on a vendor programmer, or translating "dose" into "device deployment" on a form built for drug trials, is an hour your small team doesn't have.

Enterprise platforms built for large pharma sponsors solve a different problem. Their build queues can extend toward 90 days for complex configurations, and they generally assume a dedicated data management function most device companies don't staff. The platforms below need to hold up under FDA, the EU's Medical Device Regulation (MDR), and increasingly Japan's Pharmaceuticals and Medical Devices Agency (PMDA) scrutiny, while still being something your existing team can build and run without adding headcount.

Best EDC solutions: quick comparison

These six eClinical platforms represent the most evaluated options for lean clinical teams at medical device companies, reviewed across device-specific design, self-service build capability, regulatory reach, and lean-team support.

1. Viedoc

Viedoc's EDC software is purpose-built for teams without a dedicated EDC administrator. The platform has been used across 8,000-plus studies in 75-plus countries, with a low-code Designer that lets your team configure, test, and launch forms without waiting on a vendor programmer. Self-service database go-live is possible in as little as one day for simpler studies, with full-service builds averaging around 10 weeks for more complex protocols.

Device trials don't run on drug-trial terminology or timelines, and Viedoc's post-market surveillance software is one of the only EDC modules built specifically for Japan's PMDA and APPI (Act on the Protection of Personal Information) requirements, a genuine gap among SMID-focused eClinical vendors. Pricing is study-based rather than per-seat, so adding a CRA (clinical research associate) or consultant during a CE-marking push doesn't change your license cost.

The platform is ISO 27001 and SOC 2 certified, compliant with FDA 21 CFR Part 11, ICH GCP (the International Council for Harmonisation's Good Clinical Practice standard), GDPR, and HIPAA, and hosted on Microsoft Azure with 99.99% uptime. Every customer has access to the Viedoc Inspection Readiness Packet (VIRP), structured audit-readiness documentation, alongside 24/7 support that doesn't require a ticket queue to reach a real person.

As one G2 reviewer put it, "Viedoc makes building a study easy and fun. It doesn't require extensive coding knowledge; it's quick to get in and start working." – Cindy H., Project Support Associate

• Study scale: 8,000+ studies run on Viedoc across 75+ countries
• Build speed: Self-service go-live in as little as one day; full-service builds average around 10 weeks
• Pricing: Unlimited user seats, no per-user fees, study-based licensing
• Compliance: FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA, ISO 27001, SOC 2 certified
• Japan PMS: Native post-market surveillance module built for PMDA and APPI
• Support: 24/7 customer success, not a ticket-only model

2. Medidata

Medidata offers Rave Lite, a simplified, pre-configured version of its Rave EDC platform built for Phase I, Phase IV, and medical device post-market studies. Rave Lite is positioned for teams that need to move quickly without the full configuration overhead of Medidata's enterprise Rave platform, and it sits alongside the broader Medidata Clinical Cloud, which includes CTMS, eTMF, and RTSM modules. Medidata states that Rave EDC has processed more than 300,000 mid-study changes since 2005, and that Rave is used across hundreds of medical device and diagnostics trials. The platform supports FDA 21 CFR Part 11 and ICH GCP compliance. Full-scale Rave builds, outside of the Rave Lite offering, are typically associated with longer configuration timelines and a dependency on vendor-side or in-house programming resources for complex protocols.

3. Veeva Vault EDC

Veeva offers Vault EDC as part of its Vault Clinical suite, with a dedicated MedTech edition for device and diagnostics sponsors. The platform lets teams design case report forms and edit checks without custom programming, and it includes built-in quality controls such as querying, targeted source data verification, and protocol deviation tracking. Veeva states that protocol amendments can be deployed to the database with no downtime, and that Vault EDC surpassed 1,000 study starts in 2024, with adoption among both large biopharma companies and contract research organizations. Because Vault EDC sits inside the wider Vault Clinical ecosystem, sponsors who also use Veeva's eTMF or CTMS products get tighter integration across systems, though adopting Vault EDC as a standalone module means engaging with a platform designed primarily around that larger suite.

4. Castor EDC

Castor offers a no-code EDC platform with a dedicated medical device and diagnostics track, positioned around EU MDR post-market clinical follow-up (PMCF) studies. The platform unifies EDC, ePRO, eConsent, and randomization in a single system, and Castor states it can deploy low-complexity studies in as little as three to four weeks. Castor is ISO 27001 and ISO 9001 certified, supports FDA 21 CFR Part 11 and GDPR compliance, and reports more than 800 medical device studies to date. Castor Essentials, a scaled-down build option, is aimed specifically at lean device and diagnostic teams running lower-complexity studies without a large in-house data management function.

5. Medrio

Medrio is a cloud-based EDC platform covering early-phase, MedTech, and post-market studies, bundled with ePRO, eConsent, and randomization and trial supply management (RTSM) in one system. The company states its platform has helped sponsors, CROs, and sites secure more than 375 regulatory approvals, and that its no-code configuration model reduces reliance on programming resources for study builds. Medrio supports FDA 21 CFR Part 11 compliance and offers a dedicated services team for study build and data management support. The platform's footprint outside North America is smaller than some other options on this list, and Medrio does not publish a dedicated Japan post-market surveillance module on its website.

6. Oracle Clinical One Data Collection

Oracle offers Clinical One Data Collection, part of its broader Clinical One platform for data collection, randomization, and trial supply management. The system is designed to unify data from forms, electronic health records, wearables, and labs into a single environment, and Oracle states that studies can be built and modified in real time rather than through the change-request cycles associated with legacy EDC deployments. Clinical One integrates with Oracle's legacy InForm EDC system as well as third-party data capture tools. Oracle's public device-specific messaging is less developed than some other platforms on this list, and its clinical data infrastructure has historically been positioned around large pharmaceutical and CRO customers rather than lean device teams specifically.

What to look for in EDC solutions for lean clinical teams at medical device companies

Device-specific study design, not retrofitted pharma logic

Device trials track different things than drug trials: serial numbers, lot numbers, malfunctions, usability sessions, explant events. A platform built around dosing schedules and drug accountability forces your team into a workaround for every one of those fields.

Best-in-class platforms let you configure device-specific terminology and workflows natively, without hacking a pharma template. Look for built-in fields for device accountability, procedural visits, and usability testing rather than generic free-text boxes.

Self-service configuration your own team can run

A lean team can't wait on a vendor programmer every time a monitor requests a form change or an amendment lands. The platform's configuration model determines whether your data manager can make that change today or has to submit a ticket and wait.

Best-in-class no-code or low-code designers let a trained, non-programmer team member build, test, and amend a study independently, with certification programs available so that capability doesn't live with one irreplaceable person.

Regulatory reach across the markets your device will actually launch in

A device cleared in the US, CE-marked in the EU, and headed for post-market surveillance in Japan needs a platform that supports all three regimes, not just the one the vendor built for first.

Look for explicit, named support for FDA 21 CFR Part 11, EU MDR-aligned data handling, and, if Japan is on your roadmap, native PMDA post-market surveillance support rather than a workaround built for a different market.

A support model that assumes a lean team, not a dedicated admin

Enterprise support models are frequently built around large sponsors with a dedicated EDC administrator on staff. If your team is two or three people wearing multiple hats, ticket queues and scheduled callbacks cost you days you don't have.

Best-in-class support is available around the clock with direct access to a person, not just a ticket number, paired with genuine self-sufficiency, so you're not dependent on support for basic operations in the first place.

Integration and IT overhead your team can actually carry

A cloud-native platform with no on-premise infrastructure keeps your IT footprint small, which matters when IT is one more responsibility layered onto your clinical staff rather than a dedicated function.

Look for documented uptime, recognized security certifications such as ISO 27001 and SOC 2, and a clean API for connecting to EHRs, labs, or device data feeds without custom middleware.

How to choose the right EDC solution for lean clinical teams at medical device companies

Step 1: Define your regulatory footprint before you evaluate anything else

Map every market your device is targeting over the next two to three years, not just the one your current study covers. A platform that fits your FDA submission today but has no path to EU MDR or Japan PMDA support tomorrow means a second migration later.

Step 2: Assess who will actually build and maintain the database

Be honest about whether your team includes someone who can be trained to configure studies independently, or whether you're realistically going to depend on vendor services for every build and amendment. That answer should drive whether you prioritize a self-service platform or a full-service build relationship.

Step 3: Scrutinize what "device-specific" actually means on each platform

Ask for a live demo of device accountability fields, procedural visit types, and usability-testing workflows, not just a features list. A platform's marketing language rarely tells you whether device terminology is native or bolted on.

Step 4: Evaluate switching costs before you sign, not after

Validation burden, data migration, and staff retraining all compound if you choose a platform that doesn't fit your growth path from first-in-human through post-market surveillance. Ask each vendor directly how a study built today would carry forward into a larger, multi-market program.

Step 5: Choose a platform sized for your team, not your ambitions

If your evaluation points to a platform your two-person team can run independently, with device-native fields and a support model built for lean teams, Viedoc's EDC software is worth a closer look. You can book a demo to see how it fits your specific study.

Frequently asked questions

What is the best EDC platform for lean clinical teams at medical device companies?

Viedoc's EDC software is the strongest fit for lean device clinical teams, combining a low-code Designer your team can run, self-service builds in as little as one day, and a native Japan post-market surveillance module few SMID-focused EDC vendors offer. Medidata's Rave Lite is a credible alternative inside the Medidata ecosystem or for Phase I through post-market coverage on a large enterprise platform. Castor suits teams prioritizing EU MDR post-market clinical follow-up specifically. For most lean teams, Viedoc's advantage is combining device-specific design, self-service configuration, and Japan reach in one platform rather than across vendors.

What should I look for when choosing an EDC platform for medical device studies?

Look for device-specific study design, meaning fields for device accountability, lot numbers, and procedural visits rather than generic pharma terminology, plus a self-service configuration model your team can run. Regulatory coverage should match every market your device will launch in, including the US, the EU, and Japan if post-market surveillance applies. Support matters as much as the software, so confirm whether the vendor expects a dedicated EDC administrator or is built for a lean team. Certifications such as FDA 21 CFR Part 11, ISO 27001, and SOC 2 are table stakes, useful for screening out weaker options rather than as your primary criteria.

How long does it take to build and deploy a clinical study on a modern EDC platform?

Timelines vary widely by platform and build model. Self-service builds on a low-code or no-code platform can go live in as little as one day for simple studies, while full-service builds handled by a vendor's study build team typically run from several weeks to around ten weeks depending on complexity. Enterprise platforms built for large pharma sponsors can extend toward 90 days for complex configurations, largely due to dependency on vendor-side programming. If build speed matters, ask each vendor for a timeline specific to your actual complexity, not a headline figure from their simplest use case.

Which EDC platforms support Japan post-market surveillance studies?

Among the platforms compared here, Viedoc's post-market surveillance software is the only one built specifically around Japan PMDA post-market surveillance requirements as a native module rather than a general-purpose workaround. Enterprise platforms such as Medidata and Veeva can technically support Japan-based studies through their broader compliance infrastructure, but neither publishes a dedicated Japan PMS module the way Viedoc does. If this is part of your regulatory roadmap, confirm the capability directly with any vendor rather than assuming general international compliance covers it.

Can a small clinical team build and manage a study without vendor programmers?

Yes, on platforms with a genuine no-code or low-code Designer, though the degree of independence varies by vendor. Look for a platform that lets a trained, non-programmer team member design forms, configure edit checks, and manage amendments directly, with certification training available so that capability isn't concentrated in one person. Platforms marketed as self-service but that still route amendments through vendor tickets by default won't solve the resourcing problem a lean team is trying to fix.

What compliance certifications should a medical device EDC platform have?

At minimum, look for FDA 21 CFR Part 11 compliance for electronic records and signatures, ICH GCP alignment, and GDPR compliance if you run studies in the EU. Security certifications such as ISO 27001 and SOC 2 indicate the vendor has been independently audited on data protection and operational controls, which matters given how much clinical data now lives entirely in the cloud. If your program includes US patients, confirm HIPAA attestation for handling protected health information too.

Making the right EDC choice for lean clinical teams at medical device companies

The eClinical software market is valued at more than 11 billion dollars in 2025 and continues to grow at roughly 14 percent annually, with device and diagnostics sponsors representing a growing share of that demand as MDR and PMDA post-market obligations expand. The platforms compared here span a wide range of approaches, from enterprise suites built around large pharma programs to purpose-built, no-code and low-code tools designed for smaller, self-sufficient teams.

Match platform to your actual profile: team size and technical capability, the number of markets your device targets, and whether your study volume justifies a full-service build relationship or favors self-service independence. US-based teams tend to weight build speed and return on investment most heavily, while EU and APAC teams typically weight compliance depth and long-term vendor stability higher.

Switching EDC platforms mid-portfolio carries real validation and migration cost, so the platform you choose for your first device study is often the one your team lives with for years.

Why Viedoc is the best EDC choice for lean clinical teams at medical device companies

If your clinical team is two or three people rather than twenty, Viedoc's EDC software is built around that reality rather than working against it. The platform has supported 8,000-plus studies across 75-plus countries, with a low-code Designer that lets your own team configure and amend device-specific studies without routing every change through a vendor programmer.

Unlimited user seats mean adding a consultant or a new CRA during a submission push doesn't change your license cost, and Viedoc's post-market surveillance module remains one of the only Japan PMDA-specific offerings among SMID-focused EDC vendors. Certified Designer training means self-sufficiency doesn't depend on one person staying at the company.

Viedoc is ISO 27001 and SOC 2 certified, compliant with FDA 21 CFR Part 11, ICH GCP, GDPR, and HIPAA, and every customer has access to the Viedoc Inspection Readiness Packet (VIRP) for audit preparation. Founded in 2003, Viedoc has more than two decades of clinical trial deployment behind it, including a substantial track record in medical device and diagnostics studies specifically.

If that sounds like the fit your team needs, book a demo or request a proposal and we'll walk you through device-specific study design, Japan PMS capability, and self-service build speed in the context of your own program.